Repligen Corp reports results for the quarter ended in March - Earnings Summary

Repligen

01/05/2024 14:52

* Repligen Corp  RGEN.OQ  reported quarterly adjusted
earnings of
28 cents​​ per share for the quarter ended in March, lower than
the same quarter last year, when the company reported EPS of 64
cents.  The mean expectation of twelve analysts for the quarter
was for earnings of 30 cents per share. Wall Street expected
results to range from 27 cents to 34 cents per share.
    * Revenue fell 17.2% to $151.31 million from a year ago;
analysts
expected $150.06 million. 
    * Repligen Corp's reported EPS for the quarter was 4 cents​.
    * The company reported quarterly net income of $2.09
million.
    * Repligen Corp shares had fallen by 10.7% this quarter and
lost 8.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 15.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Repligen Corp is
$215.00 
This summary was machine generated from LSEG data May 1 at 01:52
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.30           0.28           Missed
 Dec. 31 2023      0.33           0.33           Met
 Sep. 30 2023      0.17           0.23           Beat
 Jun. 30 2023      0.48           0.53           Beat